Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parrondo

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
Blood Cancer Journal|April 2, 2025
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group StudyCarlyn Rose Tan, Sireesha Asoori, Chiung-Yu Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Simplified Risk Stratification Model for Patients With Waldenström MacroglobulinemiaSaurabh Zanwar, Jennifer Le-Rademacher, Eric Durot, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Cancer|April 6, 2023
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myelomaNaresh Bumma, Binod Dhakal, Raphael Fraser, et al.
Blood Cancer Journal|March 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapyJoselle Cook, Supriya Gupta, Nadine Abdallah, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 3, 2024
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, Jacobo Pardo-Seco, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Human Vaccines & Immunotherapeutics|May 13, 2024
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocolNarmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, et al.
Blood Advances|April 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis (IEC-EC) following ciltacabtagene autoleucelKenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
Blood Cancer Journal|April 2, 2025
Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group StudyCarlyn Rose Tan, Sireesha Asoori, Chiung-Yu Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2024
Simplified Risk Stratification Model for Patients With Waldenström MacroglobulinemiaSaurabh Zanwar, Jennifer Le-Rademacher, Eric Durot, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Cancer|April 6, 2023
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myelomaNaresh Bumma, Binod Dhakal, Raphael Fraser, et al.
Blood Cancer Journal|March 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapyJoselle Cook, Supriya Gupta, Nadine Abdallah, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|May 3, 2024
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, Jacobo Pardo-Seco, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Human Vaccines & Immunotherapeutics|May 13, 2024
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocolNarmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, et al.
Blood Advances|April 10, 2026
Diagnosis and management of immune effector cell-associated enterocolitis (IEC-EC) following ciltacabtagene autoleucelKenneth Jc Lim, Hee Eun Lee, Zongming Eric Chen, et al.
Pageof 24